Frank Grillo Email & Phone Number

Los Altos, Ca, Us

San Carlos, California, Us

San Carlos, California, Us

San Carlos, California, Us

Noah Medical is building the future of medical robotics. Our next-generation robotic platform targets the early diagnosis and treatment of patients across multiple indications.

Embolx is a venture-backed start-up in Silicon Valley developing and commercializing unique catheter-based systems that enable a breakthrough in minimally invasive localized cancer therapy. Embolx devices use pressure regulation to eliminate non-target delivery and increase drug distribution in the tumor using an advanced method known as Low Pressure Embolization (LPE).

Empirical Spine is developing the LimiFlex™ Spinal Stabilization System, a novel dynamic stabilization system designed to stabilize the spine in flexion and help patients return to more healthy, active lifestyles. Pain and instability associated with lumbar flexion affect over 400,000 patients worldwide every year, creating a tremendous need for a targeted, flexion-restricting stabilization system. Limiflex is currently in a clinical trial in the United States.

• Recruited by Board of Directors as CEO for publicly traded (Australian stock exchange) medical device start-up (patient controlled tissue expanders for post-mastectomy breast reconstruction) in severe operational and financial distress• Reduced staff by 50%, while building and restructuring US sales force• Raised $15 million in equity financing in first three months in role• Company sold to private equity firm in Q3, 2019

Solana Beach, California, Us

• Joined early stage, publicly traded, commercial stage company as President, became CEO and member of the Board of Directors on January 1, 2015• Company manufactures, markets and sells the ClearPointR System, a set of navigation products and software designed to transform minimally invasive neurosurgery by enabling real-time MRI guidance during surgery• Increased revenue three-fold to approximately $2 million per quarter• Cut operating cash burn in half from over $2.5 million per quarter to $1.2 million per quarter via combination of revenue growth and headcount/expense reductions• Refocused the company on neurosurgical opportunities, while streamlining multiple offices and remote employee locations. Expanded procedural focus based on new, emerging procedures in need of highly accurate, neuro navigation technology.• Developed strategic partnerships in the neurological drug delivery market, by establishing our capability and the necessity of MRI guidance to enable infusion of drugs directly into the brain• Raised over $30 million in four rounds of new equity to continue driving the growth of the company

California, 94086, Us

Lead Marketing and Business Development for Intuitive Surgical, the world leader in minimally invasive, robotic surgery. Manage team of over 60 marketing and business development professionals, including clinical marketing, product marketing, capital marketing, patient marketing and marketing communications. Member of executive staff, growing business from $875 MM (2008) to nearly $2.2 BB (2012). Multiple product and procedure launches. Oversee licensing and acquisition function.

Hired as VP, Business Development...Promoted within six months to manage marketing. Managed over 40 marketeers, in product marketing, clinical marketing, field marketing and marcom functions. Drove acquisitions and integration of new major product line. Member of management team that grew business from $300 million to nearly $560 million in revenue. Key member of management team in sale of company to Medtronic for $3.7 billion.

Marlborough, Ma, Us

Leader of marketing function for emerging Women's Health business of Boston Scientific. Partnering closely with sales and other functions, grew business from $12 million in revenue to over $90 million in revenue over 6 years. Several product introductions and launches in women's health space, from both internal product development and acquisitions.

Marlborough, Ma, Us

Sourced, screened, prioritized, initiatated, negotiated and closed licensing, supply agreement, co-development, minority equity and acquisition deals for Boston Scientific. Supported interventional cardiology, electro-physiology, interventional radiology and drug delivery businesses of Boston Scientific. Over 200 opportunities screened, over 30 deals closed.

Managed strategy consulting projects for Fortune 500 clients. Focused on revenue growth via new markets, market segmentation and acquisition targeting.

Mba, Marketing, Finance, Operations

Bachelor Of Science, Chemical Engineering